Evidence map›Paper›PMID 18187181›Full record

ArticleHuman pathology2008

Identification of platelet-derived growth factor D in human chronic allograft nephropathy.

Gang Liu, Siribha Changsirikulchai, Kelly L Hudkins, Miriam C Banas, Jolanta Kowalewska, Xiangling Yang, Tomasz A Wietecha, John Volpone, Debra G Gilbertson, Charles E Alpers

Open access · greenAbstract read
In one paragraph

Article in Human pathology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. The PDGF family in renal fibrosis.Pediatric nephrology (Berlin, Germany) · 2012
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Gang LiuInstitute of Nephrology, Peking University, First Hospital, 100034 Beijing, China.
Siribha Changsirikulchai
Kelly L Hudkins
Miriam C Banas
Jolanta Kowalewska
Xiangling Yang
Tomasz A Wietecha
John Volpone
Debra G Gilbertson
Charles E Alpers
University of Washington · USPeking University First Hospital · CNSrinakharinwirot University · THUniversity Hospital Regensburg · DE

Funding

ROLE OF THE TUBULOINTERSTITIUM IN SALT-DEPENDENT HYPERTENSIONP50DK047659 · NIDDK · UNIVERSITY OF WASHINGTON · PI ALPERS, CHARLES · 1993 to 2002
$2.2M
PDGF-D INDUCED MODELS OF MESANGIAL GLOMERULOPATHYR21DK069912 · NIDDK · UNIVERSITY OF WASHINGTON · PI ALPERS, CHARLES E · 2004 to 2005
$303k
NIDDK NIH HHS DK47659NIDDK NIH HHS DK69912NIDDK NIH HHS R21 DK069912
6 · The paper itself

Abstract

Chronic allograft nephropathy (CAN), a descriptive term denoting chronic scarring injury of the renal parenchyma and vasculature in allograft kidneys arising from various etiologies including chronic rejection, is the most common cause of late allograft failure, but mediators of this progressive injury largely remain unknown. We hypothesized that platelet-derived growth factor D (PDGF-D) and its specific receptor PDGF-Rbeta may be an important mediator in the pathogenesis of CAN and, hence, sought to identify its expression in this setting. Allograft nephrectomies demonstrating CAN, obtained from patients with irreversible transplant kidney failure (n = 15), were compared with renal tissues without prominent histopathological abnormalities (n = 18) and a series of renal allograft biopsies demonstrating acute vascular rejection (AVR) (n = 12). Antibodies to PDGF-D and PDGF-Rbeta were used for immunohistochemistry. Double and triple immunohistochemistry was used to identify cell types expressing PDGF-D. PDGF-D was widely expressed in most neointimas in arteries exhibiting the chronic arteriopathy of CAN and only weakly expressed in a small proportion of sclerotic arteries in the other 2 groups. Double and triple immunolabeling demonstrated that the neointimal cells expressing PDGF-D were alpha-smooth muscle actin-expressing cells, but not infiltrating macrophages or endothelial cells. PDGF-Rbeta expression evaluated in serial sections was localized to the same sites where neointimal PDGF-D was expressed. PDGF-Rbeta was expressed in interstitial cells more abundantly in the CAN group compared with the normal and AVR groups, without demonstrable colocalization of PDGF-D. PDGF-D is present in the neointima of the arteriopathy of CAN, where it can engage PDGF-Rbeta to promote mesenchymal cell migration, proliferation, and neointima formation. PDGF-D may engage the PDGF-Rbeta to promote interstitial injury in chronic allograft injury, but its sources within the interstitium were unidentified.

Indexed as

Kidney TransplantationGraft RejectionHumansImmunohistochemistryKidney DiseasesLymphokinesMuscle, Smooth, VascularPlatelet-Derived Growth FactorReceptor, Platelet-Derived Growth Factor betaRenal ArteryTransplantation, HomologousLymphokinesPDGFD protein, humanPlatelet-Derived Growth FactorReceptor, Platelet-Derived Growth Factor beta

Identifiers

PMID18187181
PMCPMC2703673
OpenAlexW2113614577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.